Movement generated by the myosin motor is generally thought to be driven by distortion of an elastic element within the myosin molecule and subsequent release of the resulting strain. However, the location of this elastic element in myosin remains unclear. The myosin motor domain consists of four major subdomains connected by flexible joints. The SH1 helix is the joint that connects the converter subdomain to the other domains, and is thought to play an important role in arrangements of the converter relative to the motor. To investigate the involvement of the SH1 helix in elastic distortion in myosin, we have introduced a point mutation into the SH1 helix of Dictyostelium myosin II (R689H), which in human nonmuscle myosin IIA causes nonsyndromic hereditary deafness, DFNA17. The mutation resulted in a significant impairment in motile activities, whereas actin-activated ATPase activity was only slightly affected. Single molecule mechanical measurements using optical trap showed that the step size was not shortened by the mutation, suggesting that the slower motility is caused by altered kinetics. The single molecule measurements demonstrated that the mutation significantly reduced cross-bridge stiffness. Motile activities produced by mixtures of wild-type and mutant myosins also suggested that the mutation affected the elasticity of myosin. These results suggest that the SH1 helix is involved in modulation of myosin elasticity, presumably by modulating the converter flexibility. Consistent with this, the mutation was also shown to reduce thermal stability and induce thermal aggregation of the protein, which might be implicated in the disease process.
Class II myosins are actin-based motor proteins that drive cell motile processes including cytokinesis, migration, and morphogenesis, as well as muscle contraction (1) . Myosin II molecules consist of two identical heavy chains (HC) 3 and two pairs of light chains. The carboxyl-terminal tail region of each HC forms an ␣-helical coiled-coil rod with the tail of the adjacent HC. Myosin II molecules associate, through the tail region, to assemble into bipolar filaments, which are required for their cellular functions. The amino-terminal head region of the HC forms a globular motor domain with ATPase and motile activities. The myosin motor domain is followed by an extended ␣-helical neck region, the so-called lever arm domain, to which the two light chains bind. Structural studies revealed that the myosin motor domain consists of four major subdomains that are linked by three flexible, highly conserved joints (2, 3) . A comparison of crystal structures showed conformational changes in the motor with rearrangements of the subdomains during ATP hydrolysis. In particular, the converter subdomain rotates ϳ70°during the prestroke-poststroke transition (4, 5) . This rotation is thought to drive a long-distance swing of the lever arm domain (6) .
In a widely accepted model, the driving force for motion is generated as a result of conformational changes in the myosin head while attaching to the actin filaments. Such conformational changes cause distortion of an elastic element within the myosin molecule and allow strain to develop before movement (7) . Relief of this strain can drive relative displacement of the myosin and the actin filaments. It has been suggested that the conformational changes involve the swing of the lever arm domain relative to the motor domain. Nevertheless, the precise location of the elastic element in myosin remains unclear. Recently, Köhler et al. (8) have studied the mechanical properties of muscle fibers from patients with familial hypertrophic cardiomyopathy, and suggested that the main elastic distortion occurs within the converter subdomain or associated structures. The SH1 helix is the joint that links the converter to the NH 2 -terminal subdomain (Fig. 1A) , and is thought to play an important role in arrangements of the converter relative to the motor (3, 9) . Therefore, the SH1 helix may play an important role in distortion of the elastic element in myosin motor.
To investigate the involvement of the SH1 helix in the elastic distortion of myosin, we have introduced a point mutation in the SH1 helix of Dictyostelium myosin II. Dictyostelium discoideum contains a single myosin II gene (10) , which has been previously disrupted by means of homologous recombination to generate myosin II-null cells (11) . Wild-type and mutated myosins can readily be expressed in myosin II-null cells and characterized in vivo as well as in vitro (12) . As shown in Fig. 1B , the SH1 helix region is highly conserved in class II myosins and in Dictyostelium myosin II. The mutation replaces a conserved arginine in the SH1 helix with a histidine (Fig. 1B, bold) . This mutation in human nonmuscle myosin IIA (R705H) is linked to nonsyndromic hereditary deafness, DFNA17 (13) . Recently, Hu et al. (14) showed that mutations such as N93K and R702C, which are located within the motor domain of myosin IIA and linked to diseases, result in impairment of in vitro enzymatic and motile activities. The R705H mutation may also affect myosin II activity, whereas its effects on the in vitro activities have not been examined. In this study, we engineered the mutation at an equivalent site in the Dictyostelium myosin II (R689H), and studied motile activities and mechanical properties of the mutant protein. The mutation resulted in a significant impairment in motile activities. Single molecule mechanical measurements using optical trap revealed that the elastic property of myosin is modulated by the mutation. The mutation was also shown to affect thermal stability of the protein, which might be implicated in the disease process.
EXPERIMENTAL PROCEDURES
Construction of Plasmids-The R689H mutation was introduced into the Dictyostelium myosin heavy chain (mhc) gene (10) using two-step PCR-based mutagenesis (15) . In the first PCR, two fragments containing the mutation were generated separately. The 5Ј fragment was amplified using the 5Ј primer 5Ј-GTCATGTATGAGATTCAAGATTGG-3Ј and the 3Ј mutagenic primer 5Ј-TGGGAAACCTTTATGAGTAATACGA-3Ј. The 3Ј fragment was amplified using the 3Ј primer 5Ј-GAGTCG-GTGAGATTAGATTTGAGT-3Ј and the 5Ј mutagenic primer 5Ј-TCGTATTACTCATAAAGGTTTCCCA-3Ј. The mutagenic primers shared an overlapping region, such that these two fragments could be recombined and the whole fragment was amplified with the 5Ј and 3Ј primers through a second round of PCR. The resulting fragment was digested with BglII/NcoI, and was used to replace the corresponding region of the mhc gene in pTIKLMyDAP (16) . For expression of the S1 fragment of the mutant, the BglII-NcoI fragment of pTIKLOES1 (17) was replaced with that of the mutant.
Preparation of Proteins-Plasmids carrying either the mutant or wild-type mhc gene were introduced into Dictyostelium cells lacking the endogenous mhc gene (11) . Plasmids carrying S1 were introduced into Dictyostelium Ax2 cells. All transformants were selected in HL5 medium containing 10 g/ml G418.
Myosins were prepared by combining the methods of Clarke et al. (18) and Ruppel et al. (12) , with some modifications. In brief, washed cells were resuspended in 2.5-4 volumes/g cells in lysis buffer (20 mM HEPES (pH 7.4), 100 mM NaCl, 40 mM sodium pyrophosphate, 2 mM EDTA, 30% sucrose, 1 mM DTT, and a mixture of protease inhibitors). The cell suspension was sonicated on ice until Ͼ95% of the cells were lysed. Cell extracts were clarified by sequential centrifugation at 15,000 and 300,000 ϫ g. The resultant supernatant was dialyzed against a buffer containing 10 mM MOPS (pH 6.8), 50 mM KCl, 1 mM EDTA, and 0.5 mM DTT. After the addition of 0.1% Triton X-100 to solubilize membranes, the cytoskeletal fraction was collected by centrifugation at 15,000 ϫ g for 30 min. The pellet was washed with extraction buffer (10 mM HEPES (pH 7.4), 250 mM NaCl, 7 mM MgCl 2 , and 1 mM DTT), and centrifuged again. The resultant pellet was resuspended in extraction buffer containing 5 mM ATP, and centrifuged at 300,000 ϫ g for 30 min. The supernatant was recovered and diluted five times with a buffer containing 10 mM HEPES (pH 7.4), 10 mM MgCl 2 , 2 mM ATP, and 1 mM DTT. For phosphorylation of the regulatory light chains of myosins, the solution was incubated overnight on ice with myosin light chain kinase according to Ruppel et al. (12) . The phosphorylated myosin was recovered by centrifugation at 110,000 ϫ g for 12 min. The pellet was dissolved in a buffer containing 10 mM HEPES (pH 7.4), 250 mM KCl, 5 mM MgCl 2 , 2 mM ATP, and 1 mM DTT, and finally centrifuged at 300,000 ϫ g for 20 min to remove insoluble materials. S1 fragments were prepared as described previously (19) , with slight modifications. They were extracted from the cytoskeletal fraction with a buffer containing 20 mM HEPES (pH 7.4), 100 mM NaCl, 7 mM MgCl 2 , 5 mM ATP, and 1 mM ␤-mercaptoethanol. Once purified using a Ni-NTA-agarose column (Qiagen), the proteins were dialyzed against an assay buffer (25 mM HEPES (pH 7.4), 25 mM KCl, 4 mM MgCl 2 , and 1 mM DTT).
F-actin was extracted and prepared from acetone powder of rabbit skeletal muscle as described previously (20) . Actin concentration was determined spectrophotometrically using an extinction coefficient of 0.63 cm 2 mg Ϫ1 at 290 nm (21). Concentrations of myosins and S1s were determined by the Bradford method using BSA as standard.
In Vitro Motility Assay-Phosphorylated myosins were incubated with F-actin, and centrifuged after addition of ATP to remove denatured myosin, as described previously (22) . Myosins were introduced at a concentration of 0.1 mg/ml into a flow chamber with a nitrocellulose-coated coverslip. The surface was subsequently blocked with 1 mg/ml BSA. To assay thermally inactivated proteins, the flow chamber, containing a BSA solution, was incubated in a block incubator at 40°C for 2.5-25 min. Finally, a motility solution (25 mM imidazole-HCl (pH 7.5), 25 mM KCl, 4 mM MgCl 2 , 1 mM EGTA, 1% ␤-mercaptoethanol, and oxygen scavengers (4 mg/ml glucose, 0.2 mg/ml glucose oxidase, and 30 g/ml catalase)) containing 0.2% methylcellulose, 5 nM F-actin labeled with rhodamine-phalloidin, and 1 mM or 50 M ATP was applied to the flow chamber. The sliding of actin filaments was observed at 25°C, and analyzed as described previously (23) . Average velocity was determined by measuring displacement of actin filaments moving smoothly for 5 s or longer.
Analysis of Motility Generated by Myosin Mixtures-Under the "Appendix" of their paper, Cuda et al. (24) have proposed an analytical expression for the sliding velocity produced by myosin mixtures. Here, based on a formula obtained by Howard (25) , we provide a slightly modified expression for the sliding velocity generated by mixtures of wild-type and mutant myosins. According to a simple two-state cross-bridge model that was originally proposed by Huxley (7), Howard gave an expression for the average force as,
where is the cross-bridge stiffness, ␦ ϩ is the powerstroke distance, d is the path distance, k max is the maximum ATPase rate, t Ϫ is the drag time, and V is the sliding velocity. In a mixture of a fraction, , of the wild-type myosin and the corresponding fraction, 1 Ϫ , of the mutant myosin, the unloaded sliding velocity, V, will be the velocity for which ͗F w ͘ ϩ (1 Ϫ ) ͗F m ͘ ϭ 0, where subscripts w and m denote the contributions from wild-type and mutant myosins, respectively. As described below, a steady-state ATPase assay showed that the difference in k max between the wild-type and mutant myosins is small. Similarly, optical trap measurements showed that ␦ ϩ is similar for the wild-type and mutant myosins. Given that d is invariable, the balance of forces is given by,
where w and m are elastic constants for the wild-type and mutant myosins, respectively. Solving for the unloaded sliding velocity V,
where V w ϭ ␦ ϩ /(͌2t Ϫw ) and V m ϭ ␦ ϩ /(͌2t Ϫm ) are the sliding velocity generated by the wild-type and mutant myosins alone, respectively, and ϭ m / w is the ratio of the elastic constants of the two myosins. Velocity data of the mixtures was fitted to Equation 3 using non-linear least-squares fitting.
ATPase Assays-Basal and actin-activated Mg-ATPase activities were determined by measuring the release of phosphate at 25°C using the methods of Kodama et al. (26) . Reaction mixtures contained S1s (25-200 g/ml) and various concentrations of F-actin (0 -50 M) in the assay buffer. Reactions were started by adding 1/5 volume of 6 mM ATP, and were stopped by adding 4 volumes of 0.3 M perchloric acid. To assay thermally inactivated proteins, reaction mixtures were incubated in a block incubator at 40°C for 5-30 min before the addition of ATP.
Laser Trap Experiments-The flow chamber used in the experiments was constructed from a 24 ϫ 32-mm 2 coverslip coated with 2.3-m silica beads (Bangs Lab) suspended in 0.1% nitrocellulose in amyl acetate, and a 18 ϫ 18-mm 2 coverslip that were separated with a layer of silicon grease and two strips of adhesive tape. The chamber was first incubated with 0.25 M Ni-NTA horseradish peroxidase conjugate (Qiagen) for 3 min, followed by an addition of 1 mg/ml BSA for 3 min. Purified S1 proteins were then applied to the chamber at a concentration of 1 g/ml. At this concentration, the probability that myosinactin interaction was detected was Ͻ0.25, so that the probability that two or more myosins was bind to actin filaments would be Ͻ0.05. Following a 3-min incubation to allow the S1s to bind to the Ni-NTA horseradish peroxidase conjugate, the chamber was washed with 1 mg/ml BSA in the motility solution. Polystyrene beads (1 m, Molecular Probes) were coated with N-ethylmaleimide-myosin according to Veigel et al. (27) . Finally, the chamber was filled with the motility solution containing 5 nM F-actin labeled with rhodamine-phalloidin, N-ethylmaleimidemyosin-coated beads, and 1 M ATP, before the measurements were made.
Single molecule mechanical measurements of S1s were performed using optical trap with the "three-bead" configuration as described by other investigators (27) (28) (29) . In brief, an infrared laser (1064 nm, 1000 milliwatts, IRCL-1W-1064; CrystaLaser) was split into two beams, using polarizing beam-splitters, to trap the two beads. A N-ethylmaleimide-myosin-coated bead was caught in each of the two laser traps, and each bead was attached to the end of the fluorescently labeled actin filaments. The actin filament was pulled taut (2 pN), and positioned over a silica bead. A ϫ60 oil immersion objective lens (PlanApo, NA 1.45; Olympus) was used for the optical trapping procedures and observations of the fluorescent actin filaments. The epifluorescence images of actin filaments and beads, both of which were excited by a green laser (532 nm, 25 milliwatt, GCL-025-L; CrystaLaser) were captured by an image intensifier (VS4 -1845; VideoScope) and CCD camera (XC-ST50; Sony). The trapped bead image was illuminated by a halogen lamp and was projected onto a quadrant photodiode (S994-13; Hamamattsu-Photonics) to measure the bead displacement. The output from the quadrant photodiode was sampled at 10 kHz and stored in a personal computer by an AD converter (PowerLab/4sp, AD Instruments) to be analyzed off-line. The calibration of the bead displacement was performed by moving the stage on which the quadrant photodiode was mounted. The trap stiffness, trap , was determined by measuring the Brownian motion of the bead (variance, ͗x͘ 2 ) and applying the equipartition law (1/2 trap ͗x͘ 2 ϭ 1/2k B T) (27, 29) . The laser trap experiments were performed at 23°C at a trap stiffness of 0.05 pN nm Ϫ1 . Light Scattering-Kinetics of thermal aggregation were determined by measuring light scattering of S1 solutions at 500 nm. The absorbance of 0.3 mg/ml S1 proteins in the assay buffer was measured in 1-cm cells using a DU 640 spectrophotometer (Beckman Coulter). Samples were maintained at 40°C using circulating water. A probe thermometer (Anritsu) confirmed the temperature of cell contents. Apparent first-order rate constants of aggregation were determined from the slope of the Guggenheim plot.
RESULTS
In Vivo Functions of Myosins-To examine the effects of mutation at Arg-705 within the SH1 helix on activities of myosin II, we have engineered the mutation at an equivalent site in Dictyostelium myosin II (R689H), and expressed the mutant in Dictyostelium myosin II-null cells. We first assessed the in vivo functions of the mutant myosin. Dictyostelium myosin II-null cells were unable to grow in suspension culture or to form fruiting bodies under starvation, providing evidence that myosin II was involved in cytokinesis and morphogenesis (11) . Myosin II-null cells expressing the R689H myosin grew only slightly more slowly than cells expressing wild-type myosin (doubling time, 16.6 and 14.3 h). The cells expressing the mutant developed completely to form normal fruiting bodies comparable with those of the cells expressing the wild-type myosin (Fig. 2) . Thus, the R689H mutation only slightly affects functions of myosin II for normal growth and development of Dictyostelium cells. These results suggested that the mutant myosin retained some of the motile activities.
Motile Activities of Myosins-To reveal in vitro activities of the mutant myosin, we purified wild-type and R689H myosin proteins and determined their motile activities using an in vitro motility assay. At a concentration of 1 mM ATP, R689H myosin moved actin filaments at an average velocity of 0.4 m s Ϫ1 , whereas wild-type myosin moved actin filaments at 1.9 m s Ϫ1 (Fig. 3) . The sliding velocity generated by mutant myosin was decreased to ϳ20% of that generated by wild-type myosin. This result indicated that the R689H mutation in myosin II resulted in significant impairment in motile activity under physiological conditions. In contrast, at 50 M ATP, the wild-type and mutant myosins exhibited comparable sliding velocities (Fig.  3) . This result suggested that some steps other than ATP-induced actin-myosin dissociation were decelerated by the R689H mutation.
ATPase Activities of S1s-To determine whether the mutation affects ATPase activities in solution, we expressed mutant S1, the soluble fragment of myosin. The basal Mg-ATPase activity of R689H S1 was 1.8 times higher than that of wild-type S1 ( Table 1 ), suggesting that phosphate release was accelerated by the mutation. Fig. 4 shows actin-activated Mg-ATPase activities of wild-type and R689H S1s. They showed comparable activities over the range of the actin concentrations used. Fitting the data to the Michaelis-Menten equation yielded similar values of V max for wild-type and R689H S1s (Table 1) . These results suggested that the R689H mutant retained normal actin activation of ATPase activities. This indicated that ATPase activity was not entirely coupled to motile activity for the mutant. Furthermore, R689H showed a somewhat lower K actin ( Table 1 ), suggesting that the mutant might have a higher affinity for actin in the presence of ATP.
Single Molecule Mechanics of S1s-The sliding velocity of actin filaments in an in vitro motility assay is related to the step size and time spent in the strongly actin-bound state (30) . To determine the mechanism underlying the reduction in motility, we performed single molecule mechanical measurements of wild-type and mutant S1s using an optical trap. Here, we have used S1 fragments to reveal the mechanical properties of a single myosin head. The S1 proteins contained a His tag at the COOH terminus to be attached to the substrate via horseradish peroxidase conjugated with Ni 2ϩ -nitrilotriacetic acid. At low surface densities of the S1 molecules and in the presence of 1 M ATP, both the wild type and R689H behaved similarly to other myosin II derivatives (27) (28) (29) . They showed transient events of reduced thermal noise, presumably due to binding of a myosin to the actin filaments (Fig. 5A) . Distributions of individual mean displacements produced by wild-type or mutant S1s are shown in Fig. 5B . These were fitted by single Gaussian distributions with a S.D. matching the combined stiffness of the optical trap ( ϭ (k B T/ trap ) 1/2 Ϸ 9 nm). The average step size of the myosin working stroke can be estimated from the positional shifts of these distributions. For the wild-type and R689H S1s, the average step size was not significantly different ( p ϭ 0.32, Student's t test), with values of ϳ3 nm. Because our results were uncorrected for system elasticity, the step size may be underestimated.
In the absence of ADP and at low concentrations of ATP, the duration of myosin attachments is primarily limited by the ATP-induced actin-myosin dissociation step, with the secondorder ATP-induced dissociation rate constant (31) . Fig. 5C shows distributions of the duration of attachments for the wildtype and R689H S1s at 1 M ATP. The distributions were fitted by single exponentials with rate constants of 0.4 and 1.3 s Ϫ1 for the wild-type and R689H, respectively. The rate constant of the wild-type dissociation was comparable with that of ATP-induced actin-Dictyostelium S1 dissociation at low ATP concentrations obtained from solution studies (17, 22, 32) . These results suggested that a single myosin molecule was responsible for the individual mechanical events. The dissociation of the mutant was somewhat faster than that of the wild-type S1. This result is consistent with the finding that the wild-type and mutant myosins exhibited comparable sliding velocities at 50 M ATP in an in vitro motility assay.
We also estimated total stiffness during the attachments, by applying the equipartition law to Brownian motion of the beads (27, 29) . Fig. 5D shows distributions of the total stiffness during the attachments for the wild-type and the R689H S1s. The stiffness for the mutant was significantly lower than that for the wild-type ( p Ͻ 0.001, Mann-Whitney test). Mean stiffness values were estimated to be 0.21 and 0.12 pN nm Ϫ1 for the wildtype and mutant, respectively. In mechanical measurements with the three-bead configuration, the total stiffness of the system, total , is suggested to be a series combination of the stiffness of the cross-bridge, xb , and the actin to bead connection, con ( total Ϸ con xb /( con ϩ xb )) (27) . This implies that the estimated values may be underestimates of the true xb values. In our measurements, we used more than 20 actin filaments for both the wild-type and R689H, ensuring that the mean of con would be similar for both measurements. In this case, the ratio of xb of the wild type to that of the mutant is higher than the ratio of ͗1/ total ͘, the mean of 1/ total , of the mutant to that of the wild-type, regardless of the value of ͗1/ con ͘ (see "Appendix"). Therefore, the ratio of xb of the wild-type to that of R689H would not be less than the ratio of ͗1/ total ͘ of 1.4. Thus, although not quantitative, our result suggests that the R689H mutation significantly reduces cross-bridge stiffness.
Motile Activity of Myosin Mixtures-Single molecule mechanical measurements showed no difference in the step size between the wild-type and R689H mutant myosins. This result suggests that the slower sliding velocity of the mutant should be ascribed to the prolonged time spent in the strongly actin-bound state. Time in the strongly bound state for a mutant can be inferred from the sliding velocity produced by mixtures of wild-type and mutant myosins. If the mutant myosin is blocked in a strongly bound state, it can significantly inhibit sliding velocity generated by wild-type myosin (24, 33) . When wild-type and R689H myosins were mixed in an in vitro motility assay, the average sliding velocity was decreased on increasing the fraction of mutant myosin (Fig. 6) . The sliding velocity was somewhat decreased by mixing, suggesting that a slower sliding velocity of the R689H mutant was likely because of its prolonged strongly bound state, whereas the decrease in the velocity by mixing was less than that of the other myosin mixtures (24, 33) .
Previously, Cuda et al. (24) have proposed a simple two-state model in which sliding velocity produced by mixtures of rapidly and slowly cycling myosins can be expressed as functions of detachment rates and elastic constants for the two myosin types and a fraction of slowly cycling myosin. To better interpret the results obtained from motility of the mixtures of wild-type and R689H myosins, we slightly modified their expression to give the sliding velocity produced by the mixtures of these two myosins, as described under "Experimental Procedures." Based on the results that steady-state ATPase kinetics and the step size are only slightly altered by the mutation, the sliding velocity produced by the mixtures was shown to be related to the ratio of the elastic constants of the two myosins as given in Equation 3 . By fitting the data to the equation (Fig. 6, solid curve) , the R689H/wild-type ratio of the elastic constants was estimated to be 0.2. The dashed curve (Fig. 6) , which was obtained by assuming the two elastic constants to be equal, clearly provided a poor fit to the data. These results further supported the finding that cross-bridge stiffness was reduced by the R689H mutation.
Thermal Inactivation-The finding that the R689H mutation reduces stiffness of myosin raises the possibility that the mutation affects the flexibility and, consequently, thermal stability of the protein. To assess the thermal stability of wild-type and R689H myosins, we determined rates of thermal inactivation of S1s by measuring the remaining Mg-ATPase activities after incubation at 40°C for different time intervals (Fig. 7A) . Inactivation rates for wild-type and mutant S1s followed first-order kinetics. The apparent first-order rate constants of inactivation for wild-type and R689H S1s were determined to be 0.02 and 0.12 min Ϫ1 , respectively. This result indicated that the R689H mutant was less thermostable than the wild type.
We also investigated thermal inactivation of motile activities of wild-type and mutant myosins. The flow chambers into which myosin proteins were introduced were incubated at 40°C for different time intervals, and then motile activities were measured at 25°C using the in vitro motility assay. The number of actin filaments attached to the surface decreased upon thermal inactivation (Fig. 7B) . The decrease rate in the number of actin filaments that bound to the R689H mutant myosin was much faster than that with the wild type, further supporting the finding that the mutation reduced the thermal stability of proteins. Apparent first-order rate constants of the decrease for the wild-type and mutant myosins were estimated to be 0.04 and 0.14 min Ϫ1 , respectively. These values were comparable with those of thermal inactivation of Mg-ATPase activities, suggesting that thermal inactivation of myosin was accompanied by a loss of actin-binding activity. In contrast, the sliding velocities of the actin filaments were only slightly affected until none of actin filaments remained on the surface (Fig. 7C) , whereas their lateral motion was increased upon thermal inactivation. This was probably because thermally inactivated myosins no longer interacted with actin filaments and, consequently, did not prevent their movements produced by other active myosins.
Thermal Aggregation-Proteins often show pronounced aggregation upon thermal unfolding. Thermal aggregation kinetics of wild-type and R689H mutant S1s at 40°C were determined by measuring light scattering at 500 nm (Fig. 8) .
Assuming that absorbance was proportional to the amount of aggregated proteins, and that aggregation followed first-order kinetics, the time course of light scattering was given by A ϭ A ∞ {1 Ϫ exp[Ϫk (t Ϫ t 0 )]}, where t is time, A is absorbance, A ∞ is the limiting value of A at t 3 ∞, k is the apparent first-order rate constant, and t 0 is the value of t at which A ϭ 0 (34). By fitting data to this equation, the apparent first-order rate constants of aggregation of the wild-type and R689H were determined to be 0.03 and 0.15 min Ϫ1 , respectively. Thus, the R689H mutation accelerated thermal aggregation of the protein. Rate constants of aggregation were similar to those of inactivation of ATPase activity. Thermal denaturation of proteins is often described in terms of a simple kinetic model (35) , N 7 U 3 I, where N is the native state, U is the unfolded state, and I represents the final irreversible denatured state, which often forms aggregates. ATPase activity and light scattering are proportional to the concentrations of N and I in the scheme, respectively. Similarities between rate constants for aggregation and inactivation suggested that the unfolding transition (N 3 U) was the ratelimiting step of the thermal denaturation process of myosin.
DISCUSSION
The R689H mutation within the SH1 helix in Dictyostelium myosin II resulted in significant impairments in motile activities. In contrast, actin-activated ATPase activity of the mutant was comparable with that of the wild type. These results indicate that the mutation reduces coupling between ATPase and motile activities. In a simple model, the sliding velocity of actin filaments moved by an ensemble of myosin molecules is expressed as V Ϸ d/t on , where d is the step size of working stroke and t on is the time spent in the strongly actin-bound state (30) . In single molecule mechanical measurements using an optical trap, we found no difference in bead displacements between the wild-type and mutant myosins. Veigel et al. (27) suggested that the observed bead displacement is smaller than the step size of the working stroke, because the actin to bead connection is extended by the stroke. Because our results were uncorrected for system elasticity, the step size may be underestimated. As discussed later, the cross-bridge stiffness was lowered by the R689H mutation. Because the observed bead displacements are thought to decrease as the cross-bridge stiffness is lowered (27), we could not rule out the possibility that the step size was lengthened rather than unaltered by the mutation. In either case, the slower sliding velocity for the mutant would be caused by altered t on .
Mixing wild-type and R689H mutant myosins resulted in some reduction in sliding velocity in our in vitro motility assay. This further supports the idea that an increase in t on is responsible for the slower motility of the R689H mutant. The lifetime of the strongly actin-bound state in the absence of ADP and P i is related to k ϪD and k T as t on ϭ 1/k off ϭ 1/k ϪD ϩ 1/(k T [ATP]), where k ϪD is the ADP release rate and k T is the second-order ATP-induced actin-myosin dissociation rate (36) . This implies that t on is limited primarily by k ϪD at high ATP concentrations, but by k T at low ATP concentrations. Single molecule measurements showed that, at 1 M ATP, the ATP-induced actin-myosin dissociation step of the mutant is somewhat faster than that of the wild type. Consistent with this, at 50 M ATP, both wild-type and mutant myosins exhibited comparable sliding velocities. These results suggest that a deceleration of steps other than ATP-induced dissociation, possibly ADP release, may contribute to impairment in motile activity of the R689H mutant at physiological ATP concentrations.
Single molecule mechanical measurements demonstrated that the R689H mutation affected the cross-bridge stiffness during attachment. In our study, the cross-bridge stiffness was not quantitatively determined because of uncertainty of compliant elements in the experimental system, especially the actin to bead connection. Nevertheless, given that the connection compliance is similar for both wild-type and R689H measurements, the observed difference of the total stiffness should be ascribed to that of the cross-bridge stiffness, as described under "Results" and "Appendix." In addition, the sliding velocity produced by mixtures of wild-type and mutant myosin was interpreted in terms of the simple two-state cross-bridge model, also suggesting that the mutation reduced the elastic constant of cross-bridge. Taken together, these results indicate that the elasticity of the myosin motor is modulated by the mutation within the SH1 helix.
Recently, Köhler et al. (8) investigated mechanical properties of muscle fibers from patients with familial hypertrophic cardiomyopathy and concluded that the main elastic distortion occurs within the converter subdomain or associated structures in the myosin head. Our finding is consistent with this notion because the SH1 helix is the joint that links the NH 2 -terminal subdomain to the converter (Fig. 1A) , and is thought to play a role in arrangements of the converter relative to the motor (3, 9) . The SH1 helix region contains two reactive cysteine sulfhydryls, SH1 and SH2, which can be cross-linked in the presence of nucleotides (37, 38) . These experiments are accounted for by the structure of the myosin motor domain in which the SH1 helix is unwound (3). The unwinding of the helix effectively uncouples the converter from the rest of the motor and allows the converter to adopt multiple conformations. From these studies, it is proposed that the SH1 helix is a kind of clutch that controls coupling between the converter and the motor (9) . In the SH1 helix, the R689H mutation may destabilize the structure of the helix, and thus induce uncoupling of the converter from the motor. As a result of the uncoupling, the motor domain is likely to become more flexible and the resistance of the converter to elastic distortion is likely to decrease.
The idea that the R689H mutation reduces flexibility of myosin is supported by the finding that the mutation resulted in a reduction in thermal stability of the protein. This finding is based on the results that thermal inactivation rates of ATPase and actin-binding activities were increased about 5-fold by the mutation. Inactivation rates of ATPase and the actin-binding activities were similar, suggesting that both inactivation processes were caused by the same thermal unfolding process of myosin. In contrast to ATPase and actin-binding activities, the sliding velocity of actin filaments was only slightly affected by thermal inactivation until no actin filaments remained on the surface. These results suggest that thermally unfolded myosin completely loses its actin-binding activity, and consequently does not inhibit sliding produced by other myosin proteins.
Thermal aggregation of myosin II was accelerated by the R689H mutation. Aggregation rates of myosins were comparable with those of thermal inactivation, suggesting that the aggregation is induced by thermal unfolding of the protein, as for other proteins. Therefore, the higher tendency for aggregation of the mutant is ascribed to the lower thermal stability of the protein. Recently, some mutations in the human nonmuscle myosin IIA HC gene were linked to a number of platelet disorders such as the May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes (39 -41) . Most of the nonmuscle myosin IIA-related disorders share leukocyte inclusions, which were recently shown to contain cytoplasmic aggregates of myosin IIA (42) . Mainly the aggregation is caused by mutations in the COOH-terminal tail region responsible for filament assembly (43) (44) (45) . However, mutations in the motor domain such as N93K, S96L, R702C, and R702H also cause aggregation of protein in cells, seen as speckled small dots distributed throughout the cytoplasm (43, 44) . Correspondingly, Hu et al. (14) noted that the N93K mutant has a higher tendency for aggregation in vitro. Because these mutations lie in close proximity to the SH1 helix, it is likely that they also reduce thermal stability and induce aggregation of the protein as shown for the R689H mutation. The R705H mutation in nonmuscle myosin IIA (homologous to R689H in Dictyostelium myosin II) is linked to DFNA17, a nonsyndromic hereditary deafness with no apparent involvement of platelets (13) . It has not been determined whether patients with DFNA17 also show cytoplasmic aggregates of myosin in cells. However, here, we showed that the mutation induced thermal aggregation of the protein in vitro. This raises the possibility that the reduction in thermal stability as well as motile activity of myosin II might contribute to the disease process. Further studies will be necessary to test this possibility. ilar for both measurements. Then from Equation A2, the ratio of xb of the wild type to that of the mutant is given by, xb,w / xb,m Ϸ (͗1/ total,m ͘ Ϫ ͗1/ con ͘)/(͗1/ total,w ͘ Ϫ ͗1/ con ͘) (Eq. A3)
where subscripts w and m denote the values for wild-type and mutant myosins, respectively. From Equation A1, it is obvious that ͗1/k con ͘ Ͻ ͗1/ total,w ͘. The experiments indicated that ͗1/ total,w ͘ Ͻ ͗1/ total,m ͘. Then we obtain the following equation.
xb,w / xb,m Ͼ ͗1/ total,m ͘/͗1/ total,w ͘ (Eq. A4) Thus, the ratio of xb of the wild type to that of the mutant is higher than the ratio of ͗1/ total ͘ of the mutant to that of the wild type, regardless of the value of ͗1/ con ͘.
